View Article

Abstract

Nanotechnology has revolutionized modern science through its ability to manipulate materials at the molecular and atomic levels, leading to significant advancements in drug delivery, diagnostics, and therapeutic applications. This review provides an overview of important nanomaterials such as solid lipid nanoparticles (SLNs), nanogels, nano-emulsions, and nanoparticles, emphasizing their classification, synthesis, and biomedical relevance. These nanoscale systems exhibit unique physicochemical properties—including enhanced solubility, targeted delivery, biocompatibility, and controlled release—making them ideal for pharmaceutical applications. Nanogels, for example, demonstrate responsiveness to environmental stimuli, offering promise in gene therapy and cancer treatment. Similarly, nano-emulsions enhance the bioavailability of hydrophobic drugs, while SLNs serve as efficient carriers for poorly soluble therapeutic agents. The integration of organic, inorganic, and carbon-based nanoparticles has expanded the scope of nanomedicine, enabling more precise and efficient therapeutic outcomes. Despite the remarkable progress, challenges such as large-scale production, stability, and toxicity remain barriers to clinical translation. This article summarizes the recent developments and applications of key nanomaterials and provides insights into their future prospects in drug delivery and biomedical sciences.

Keywords

Nanotechnology, Solid Lipid Nanoparticles, Nanogels, Nano-emulsion, Drug Delivery, Nanoparticles etc.

Introduction

Introduced in 1991, solid lipid nanoparticles (SLN) are an alternative to conventional colloidal carriers like emulsions, liposomes, and polymeric micro and nanoparticles. Solid-based nanoparticles are garnering significant interest as a novel colloidal drug carrier for intravenous applications because they have been suggested as an alternative particulate carrier system. Sub-micron colloidal carriers (SLN) are made of physiological lipid and are distributed in water or an aqueous surfactant solution. They have a diameter of 50 to 1000 nm. Small size, high drug loading, vast surface area, and phase interaction at the interface are some of the special qualities that SLN offer. They are also appealing because of their potential to enhance pharmacological performance [36]. SLNs have a mean diameter of 50–1000 nm and are morphologically spherical, smooth surfaces. Both behaviors in vitro and in vivo rely on how SLNs are physicochemically characterized (Fig. 1)[1].

Fig. 1: Structure of SLNs [1]

Nano-formulations include drug particles at the nanoscale that are made with nanotechnology or have been integrated with nano-formulations to provide a revolutionary drug delivery system. In the 1960s, nano-formulation began to be used in the pharmacological and medical domains (fig. 2) [3].

Fig.2: The historical development of nano-formulations [3]

A very versatile family of nanocarriers, lipid-based nanoparticles (LNAPs) have become widely used in pharmacology and medical research [4]. The main obstacle to medication administration in the posterior portion is the blood-retinal barrier. The most popular and straightforward method of delivering medication to the anterior segment is topical administration, similar to eye drops [4].  Nanoemulsions (NEs) are colloidal dispersions that are nanometers in size. They usually consist of an oil phase that is dispersed in an aqueous phase (oil-in-water, O/W) or vice versa (water-in-oil, W/O). Bicontinuous and multiple NEs (MNEs) are examples of additional categories, such as oil-in-water (O/W/O) or water-in-oil-in-water (W/O/W) [21]. In the nanoscale size range, nanogels are three-dimensional hydrogel materials made of networks of crosslinked, swellable polymers that have a high capacity to retain water without truly dissolving in the aqueous medium. Their architecture's adaptability permits the addition of a wide variety of guest molecules, from inorganic nanoparticles to biomacromolecules like proteins and DNA, with the appropriate adjustments to the materials used in their production, all without affecting their gel-like properties [34]. Nanogels (NGs) for drug delivery, gene therapy, and nanohydrogels have been developed as a result of recent developments in nanomedicine. They are appropriate for biomedical applications since they are frequently biocompatible. Hydrogels come in a wide range of sizes, from a few micrometers to several centimeters, and are employed in a variety of fields, including bandages, tissue engineering, cosmetics, and medical equipment[26]. There are currently only 15 cancer medications based on nanoparticles available on the market, compared to decades before. Limited scalability, inadequate control over reaction parameters, nanoparticle polydispersity, inadequate batch-to-batch repeatability, and high chemical reagent volumes—including pharmaceuticals—are the hurdles in nanoparticle translation[26]. Depending on their intended uses and desired characteristics, nanogels can be made of a wide range of natural or synthetic polymers. The following are examples of natural polymers: (a) chitosan, which is derived from chitin and is known for its antimicrobial, biocompatible, and biodegradable qualities; (b) alginate, which is extracted from algae and is valued for its ability to form gels in the presence of divalent ions like calcium; (c) hyaluronic acid, which is a naturally occurring component of the extracellular matrix and is chosen for its highly effective water retention; and (d) polysaccharides, such as those found in natural gums[23].
Nanogels are non-toxic to the tissue microenvironment and exhibit extremely high stability in physiological fluids[26] Because of their robustness and similarity to human tissues, they are able to withstand shear forces and blood serum proteins. Table 1 lists the most current systems based on nanogel technology, demonstrating its multifunctional qualities that are beneficial for a range of illnesses [26].

Table 1: Recent advancements in nanogels used for various diseases [26]

Sr. no

Nanogel Matrix Materials

Synthesis Method

Imaging Agent

Therapeutic Delivered

Disease

1

Polysulfamide-based poly[2-((2-(methacryloyloxy)ethyl)dimethylammonio) acetyl)(phenylsulfonyl)amide (PMEDAPA) nanogels

Aqueous precipitation polymerization

Fluorescent dye Cy5-modified PMEDAPA nanogels are used to visualize the behaviours of nanogel

Doxorubicin hydrochloride (DOX)

Cancer therapy

2

Dual enzymes lactate oxidase (LOD) and catalase (CAT) encapsulated into the self-assembled nanogels to fabricate responsive nanoprobes LOD/CAT-loaded nanogels (LCNGs)

Supramolecular chemistry

Enzymes substrates

3

Gold NGs (GAuNGs) composed of thermoresponsive linear poly(glycidyl ether)(tPG) chains cross-linked by small AuNPs

Thermo-nanoprecipitation

NIR absorption capable GAuNGs

(DOX)

4

Near infrared (NIR)-responsive CuS?-loaded nanogels

Reflux-precipitation polymerization

CuS/Cy-7

(DOX)

5

Zwitterionic nanogels based on poly(sulfobetaine methacrylate) (PSBMA)

One-step reflux-precipitation polymerization

Levofloxacin (LEV)

Ophthalmology application

6

Penetratin-complexed, redox-responsive hyaluronic acid-based nanogels

EDC coupling protocol

Carbon dots (CD)

9-cis-Retinal

7

NIR activable biomimetic ARNGs@TMZ/ICG nanogel

Cross-linking by pullulan and poly(deca-4,6-diynedioic acid)(PDDA) and loaded with temozolamide and indocyanine green (ICG)

Green fluorescence labelled CD31 antibody used to absorb penetration of nanogels into the tumor

Temozolamide and indocyanine green (ICG)

Neurological disorders

8

A jelly formulation containing M. pruriens seed-extract nanogel

Ionic gelation

Levodopa (L-dopa)

9

Sulfated nanogels (NGs) based on dendritic polyglycerol sulfate (dPGS)

Inverse nanoprecipitation technique based on a bio-orthogonal click reaction

Potent inhibitors for HS-binding viruses

Anti-viral application A

Classification

1. Solid-Lipid Nanoparticles (SLNs)

Three major forms of SLNs can be distinguished based on drug loading: [40,41]

  1. Homogeneous matrix
  2. Drug-enriched shell
  3. Drug-enriched core

Fig:3 A) Homogenous matrix, B) Drug-enriched shell, C) Drug-enriched core [40,41]

Through careful formulation procedures like high-pressure homogenization above the lipid melting point or cold homogenization methods, the homogeneous matrix model exhibits a uniform distribution of drug molecules spread throughout the solid lipid core. In addition to improving therapeutic efficacy and stability by avoiding crystallization or phase separation, this strategy guarantees consistent drug encapsulation and controlled sustained release. It is especially well-suited for uses that call for enhanced bioavailability and sustained pharmacological activity. Conversely, the outer shell of the nanoparticles is where the drug is mostly concentrated in the drug-enriched shell model. While the drug becomes enriched and trapped in the solid-lipid outer shell, which subsequently hardens and encapsulates the drug on the surface, the lipid core of a hot lipid nano-emulsion initially solidifies during cooling. Although it might not be as suitable for prolonged release, this design offers quick or burst release, which is beneficial in situations requiring focused administration or an instant therapeutic effect. The inner core of the nanoparticles contained a high concentration of the drug, according to the drug-enriched core model. Before lipid recrystallization, drug molecules precipitate inside the lipid matrix when it cools, creating a drug-rich core encased in a protective lipid shell. By demonstrating drug diffusion across the lipid barrier, this arrangement protects delicate medications and offers extended, regulated release. It is perfect for treatments that call for prolonged drug release patterns and defense against degradation of the active ingredient; see figure 4. [40, 41, 52, 50]

2. Nanogels

The classification of nanogels is mentioned in Fig. 4[24]

Fig:4 classification of nanogels [24]

1. Nanogels are categorized based on their structural properties.

Fig. 5 lists the different kinds of nanogels. [24]

Fig:5 types of nanogels based on structure [24]

  1. Hollow nanogels:

An empty core cavity is part of the structure of hollow nanogels. Core-shell particles (such as silica, gold, and HPC) are used in the creation of hollow nanogels, and the core is then removed (either by solvent precipitation or a pH gradient). Large surface area and a hollow interior for loading or trapping are two benefits of hollow nanogels.

  1. Multilayered nanogels:

 Multiple layers of one or more polymers make up the structure of these nanogels. Sequential polymer layering,  occasionally with crosslinking, is the preparation method. Its benefits include a high site specificity, a customizable drug release profile, and suitability for highly potent or fragile medications.

  1. Core-shell nanogels

Metal, a nanorod, and a carbon-based nanomaterial make up the structure. The polymeric or organic shell encloses the center. Functional characteristics like optical, magnetic, and conductive are provided by the core, while the shell manages stability and release.

  1. Hairy nanogels

This nanogel's structure consists of surface-grafted, hair-like polymer chains, sometimes referred to as polymer brushes. It is prepared via controlled radical polymerization techniques or macro-RAFT agents [24].

2. Nanogels are categorized according to how responsive they are to different environmental stimuli.

  1. When non-responsive nanogels come into contact with aqueous fluids, they swell through simple absorption, removing the need for external triggers to continuously release medications at the desired site.
  2. sensitive nanogels, in response to changes in electrical power, pH, light, magnetic field, ultrasound, ion strength, or solvent composition. It is possible for responsive nanogels to swell or deswell. These stimuli Both natural and synthetic polymers are commonly used to create responsive nanogels, which have a remarkable capacity to absorb water and swell in response to a variety of physical, chemical, and biological stimuli. Nanogels that react to many stimuli are referred to as multi-responsive nanogels. Because of their ability to undergo reverse expansion and deswelling in response to various triggers, responsive nanogels are a valuable substrate for biomedical applications. Targeted and controlled drug delivery is made possible by this feature.

3. Linkage-based nanogels:

  1. non-covalent linkage

Ionic, surface/interface, adsorption, and van der Waals forces are examples of self-assembled interactions that don't        require cross-linking agents. They don't need chemical reagents to lessen toxicity because this kind of connection is reversible. It enables regulated release and dynamic responses. However, it is unstable and quite weak. For example,    micellar nanogels, liposome-modified nanogels, and physically cross-linked nanogels.

  1. Covalent Linkage [24]

Its stable bonds indicate that the coupling is stoichiometrically controlled and permanent. They have stable structures and a high mechanical strength. Their qualities are precisely tuned and they are resilient. Additionally, they are helpful for stimuli-responsive or regulated release.

4. Polymer-based nanogels:

Drug delivery systems based on oligosaccharide-based nanogels are becoming more popular due to their safety, biodegradability, and ease of modification. Usually created by the interaction of naturally occurring polymers with positive and negative charges, they are able to react to variations in the pH of the body. For example, without the need for additional surfactants, chitosan nanogels serve as natural emulsion stabilizers. They can also be cross-linked to increase their stability for medicinal applications. Pullulan nanogels are useful in drug and protein delivery because they are very effective at preventing proteins from clumping or breaking down, especially when modified with cholesterol[37,38].

Particularly intriguing are hyaluronic acid (HA) nanogels, which have the inherent capacity to target particular cells due to their natural binding to the CD44 receptor, which is present on the surface of many cells. Alginate nanogels are especially effective in protecting delicate proteins during oral delivery, even in the stomach's acidic environment, and they may be chemically altered to change how they dissolve. Utilizing its donut-like shape, cyclodextrin nanogels enhance the solubility of hydrophobic medicinal molecules by trapping and transporting them. Last but not least, gum acacia nanogels, which are derived from the natural gum of acacia trees, are affordable, environmentally benign, and extremely soluble in water. As such, they may be readily combined with other polymers, such as chitosan, to deliver drugs. All things considered, these various varieties of polysaccharide nanogels demonstrate how natural materials can be transformed into an excellent instrument for safer, more effective, and targeted treatments. [43]

3.  Nanoemulsions

Types of Nanoemusion: [44,52]

  1. Oil-in-water
  2. Water-in-oil
  3. Biocontinuous

Emulsions represent an important class of pharmaceutical dosage forms in which one liquid is dispersed as small droplets within another immiscible liquid, stabilized with the aid of emulsifying agents. Their significance in pharmacy arises from their ability to improve drug solubility, mask unpleasant taste, enhance absorption, and permit controlled drug release. pharmaceutical emulsions may be oil-in-water(O/W) or water-in-oil (W/O), with their application ranging from oral, topical, and parenteral delivery to cosmetics to conventional emulsions, advanced systems such as nanoemulsions and microemulsions have gained increasing attention due to their small droplet size, high stability, and improved bioavailability of poorly soluble drugs. [46,47]

With droplet sizes of less than 200 nm, nanoemulsions are kinetically stable but thermodynamically unstable dispersions that are primarily categorized by their composition and dispersed phase type. Oil-in-water (O/W) nanoemulsions, in which oil droplets are distributed throughout an aqueous phase, are the three main varieties.[35,36]

frequently used to increase the solubility and absorption of lipophilic drugs; bicontinuous nanoemulsions, where both the water and oil domains interpenetrate and provide benefits in solubilizing both hydrophilic and lipophilic drugs; and water-in-oil (W/O) nanoemusions, where water droplets are distributed in a continuous oil phase and are frequently used in topical, cosmetic, and transdermal applications. Each kind has distinct biological and physical characteristics that affect its stability, drug release profile, and potential for use in pharmaceuticals. Nanoemulsions are extremely adaptable carriers in modern pharmacy because they may be customized for oral, parenteral, or topical administration systems by carefully choosing the formulation components. [45,46,51,52]

4. Nanoparticles

Fig:6 classification of nanoparticles [48,49]

Nanoparticles are classified into three main types:

  1. Organic nanoparticles
  2. Inorganic nanoparticles
  3. Carbon-based nanoparticles
  1. Organic nanoparticles (ONPs)

ONPs are made from organic compounds and are less than 100 nm. Ferritin, micelles, dendrimers, and liposomes are a few examples; many of them are hollow nanocapsules that can transport medications. Their primary benefits-biodegradability, non-toxicity, and light and heat responsiveness-make them ideal for use in biomedicine. Particle size, surface form, stability, and drug-loading techniques (entrapped or absorbed) all affect how well they transport drugs. ONPs are frequently utilized in regulated and targeted drug delivery systems due to their ability to target particular bodily areas [48,49].

Fig:7 Types of organic nanoparticles: A) Dendrimers B) Liposomes C) Micelles     D) Ferritin [48]

  1. Inorganic nanoparticles The structure of inorganic nanoparticles is made up of carbon atoms and metals or metal oxides. Due to quantum confinement and coulomb charge effects, they exhibit distinct quantum size effects, high surface-to-volume ratios, size-dependent characteristics, and optical behaviors that are very different from those of bulk materials [49].
  1. Metal- based nanoparticles

Gold, silver, copper, iron, zinc, and cobalt are among the elements that can be used to create metal nanoparticles, which have remarkable electrical, thermal, antibacterial, and catalytic capabilities. Surface behavior is improved by their nanoscale size. These nanoparticles, which have customizable size and shape, are used in environmental sensing, chemical catalysis, and biological imaging because of their potent surface activity and quantum phenomena. [49]

  1. Metal oxide-based nanoparticles. Because they are more stable, reactive, and efficient than their metallic counterparts, metal oxide nanoparticles (such as TiO2, ZnO, SiO2, and Al2O3) are being researched extensively. Strong electrostatic connections are created when positive metal ions and negative oxygen ions interact ionically to generate them. Iron nanoparticles, for example, easily oxidize to Fe2O3, which increases their reactivity. Metal oxides are employed in photocatalysis, energy storage, sensors, and catalysis due to their functional characteristics and chemical stability.[48,49]
  1. Carbon based nanoparticles

Carbon-based nanoparticles have special electrical, thermal, and structural characteristics. They are made from carbon allotropes such as graphite, diamond, graphene, carbon nanotubes (CNTs), and fullerens. Their strong covalent structures and adaptable bonding enable them to be used in biological, electronics, energy storage, and water treatment applications. While CNTs and activated carbon are useful for adsorption, catalysis, and separation processes, graphene, a single-atom-thick sheet with exceptional strength and conductivity, is used as a building block for other carbon nanostructures. [48]

a) Fullerenes

Buckminsterfullerene (C60), in particular, is a spherical carbon molecule made up of 60 carbon atoms put in a cage-like structure that resembles a soccer ball. They have special physicochemical characteristics due to their symmetrical geometry and resonance stabilization. Derivatives of C60, including nanorods, nanotubes, and nanosheets, are utilized in material science, catalysis, and nanoscience. Applications in medication delivery, polymer development, and environmental cleanup are made possible by their capacity to undergo covalent and supermolecular modifications. [48,49]

Fig:8 types of carbon-based NPs: A) C 60 fullerence; B) carbon black NPs; C) carbon quantum dots [48]

 b) Graphene and graphene oxide

 Graphene and its derivative, graphene oxide (GO), have shown great promise in the creation of polymer-based nanocomposites because of its exceptional barrier qualities, electrical conductivity, and mechanical strength. Although pure graphene has many benefits, its large-scale use is hampered by issues including agglomeration, poor solubility, and the complexity of bottom-up synthesis. Conversely, GO is easily synthesized from carbon sources using top-down techniques, and because it contains functional groups that contain oxygen, it has great solubility and may effectively modify its surface. These characteristics improve GO dispersion in polymer matrices, which raises the overall effectiveness of nanocomposites. Furthermore, GO's sp2-hybridized carbon network effectively blocks gas diffusion, which makes it ideal for use in innovative packaging materials, corrosion resistance, and protective coatings for delicate electronics. [48]

Literature Review

Sr No.

Title

Discription

Ref.

No.

1.

Solid lipid nanoparticles: Preparation techniques, their characterization, and an update on recent studies

Key Points: Solid lipid nanoparticles, carrier system, nanomedicine, biocompatibility, nanotechnology

Nenotech Type: Nanocolloidal system for drug delivery

Focus: Enhance Bioavailability

Size: 0.05-1 µm

1

2.

Solid Lipid Nanoparticles for DrugDelivery: Pharmacological and

Biopharmaceutical Aspects

Key Points: clinical trials, drug delivery, nanostructured lipid carriers, nanotoxicity, pharmacokinetics,

pharmacodynamics, routes of administration, and solid lipid nanoparticles

Nenotech Type: Nanosized drug delivery systems

Focus: Disposition in the Body and Penetration to the CNS, Gastrointestinal Absorption of Lipid-Nanoparticles, Systemic Circulation and Protein Corona

Formation.

Size: 0.001-1µm

2

3.

Nano?formulations in disease therapy:

designs, advances, challenges, and future

directions

Key Points: Nano-formulations, Design strategies, Disease therapy, Hybrid nanoparticle

Nenotech Type: Innovative drug deliverysystem

Focus: malignant tumors, chronic pulmonary conditions, complex cardiovascular diseases, or refractory conditions such as diabetes, fragile ocular diseases, and recalcitrant dermatological disorders, thereby enabling more

precise and effective therapeutic interventions.

Size:0.01-0.2µm

3

4.

Lipid-Based Nanoparticles for Drug/Gene Delivery: An Overview of the Production Techniques and Difficulties Encountered in TheirIndustrial Development

Key Points: Manufacturing, Lipid-based nanoparticles, Delivery systems, Lipid-based nanoparticle synthesis, Industrial challenges

Nenotech Type: Novel drug delivery systems

Focus: Liposomes, nanostructured lipidCarriers, lipid polymer hybrid

Nanoparticle.

Size: SLNs 0.05-1µm

Small Unilamellar Liposomes size of <1 µm

4

5.

Nano-formulations in pharmaceutical and biochemical applications: Green perspectives

Key Points: Nano-therapy; Nanopharmaceuticals; biomaterials; photo-nanotheranostics; biomimetics; biomimetics; bioinspiration; cyborg cells; green design

Nenotech Type: Nanomicelles, lipid-based nanoparticles, liposomes, Dendrimers, carbon nanometrials, metal-based nanopaticles, quantum dots, metal-oraganic frameworks, bio-nanopharmaceuticals

Focus: Nanotechnology in pharmaceutical and biomedical applications, nanoformulations.

Size: 0.01-1 µm

5

6.

Recent trends in nanoparticle-based drug delivery for tuberculosis treatment

Key Points: Biodegradable, Drug delivery, Nanoparticles, Nanoencapsulation

Nanotech type: Chitsan nanoparticles, PLGA nanoparicles

Focus: Nanoparticles-based drug delivery system for tuberculosis treatment.

Size: < 1µm

6

 
 

7.

Nanoparticles in drug delivery: from history to therapeutic applications

Key Points: Drug delivery; Nanomedicine; therapeutics; Personalized medicine

Nenotech type: Polymeric nanoparticles, solid-lipid nanoparticles, liposomes, nanoemulsion, metallic nanoparticles, mesoporous silica, chitosan nanoparticles,

Focus: Targeted drug delivery.

Size: 0.01-1 µm

 

7

8

Emerging Nano-formulations and nanomedicines applications for ocular drug delivery

Key Points: Organic and inorganic nanoparticles; ophthalmic applications; clinical trials

Nanotech type: liposomes, niosomes, dendrimers, inorganic nanoparticles ex; gold NPs

Focus: Nanotechnology in ocular drug delivery.

 

8

9

Review on Nano-emulsions drug delivery system and formulation, evaluation and their pharmaceutical application

Key points: Nano-emulsion, Types of nano-emulsion, surfactants, Novel drug delivery, pharmaceutical application

Nanotech type: Novel drug delivery by nano-emulsion

Focus: Advantages, limitations, basic information, all types of nano-emulsion drug delivery.

Size: 0.05-5 µm

9

10

Basic concepts and recent advances in nanogels as carriers for medical applications

Key points: Nanogel, response to external stimuli, nano-carrier, drug release, physical and chemical cross linking, genetic material, protein and vaccine delivery

Nanotech type: Nanogels, hydrogels particles, crosslinked polymer network at nanoscle and stimuli-responsive nanogels

Focus: Nanogels as nanocarriers, how nanogels integrate in the nanomedicine and nanogels features and advantages, prepration techniques.

11

11

Modern herbal nanogels: formulation, delivery methods, and applications

Key points: nanogels; herbal bioactives; hydrogels; polysaccharides

Nanotech type: Herbal-based nanogels

Focus: herbal nanogels use as nanocarrriers.

Size: standard Description: 1 µm

Accepted Dimensions: 2 µm

Frequent Range: 1-0.1 µm

12

12

Advances in nanoparticles in targeted drug delivery-a review

Key points: Nanoparticles; drug delivery; nanomedicine; biocompatibility; therapeutics

Nanotech type: Physically cross-linked vs chemically cross-linked nanogels, stimuli-responsive nanogels, morphological variants

Focus: Nanogels as advanced drug delivery system for dermal and transdermal routes.

13

13

Hybrid hydrogels incorporating nanoparticles, their types, development, and applications; a comprehensive review of nanogels

Key points: hydrogels, nanoparticles

Nanotech type: Stimuli-responsive nanogels

Focus: use of nanogels as efficient drug delivery systems for dermal and tansdermal applications.

14

14

Nanogels as novel drug nacarriers for CNS drug delivery

Key points: Nanogels, blood-brain barier, blood cerebrospinal fluid barrier, brain targeting, drug delivery, CNS

Nanotech type: Stimuli-responsive,

biocompatible, cross-lined polymeric nanogels for brain targeting

Focus: Nanogels as novel drug nanocarriers for CNS drug delivery

15

15

Nanoemulsions: summary of a decade of recent advances

Key points: applications, emulsifiers, methods of preparation, nanoemulsion, route of administration, screenings, surfactant

Nanotech type: Nanoemulsions-submicron-sized emulsions stabilized by surfactants

Focus: Nanoemulsions technology.

Size: typical size: less than 2 µm

CNS Delivery: 0.2-2 µm

16

16

Recent trends in nanoparticlesbased drug delivery for tuberculosis treatment

Key points: Biodegradable, Drug delivery, nanoparticles, nanoencapsulation

Nanotech type: Polymericnanoparticles used for sustained and targeted delivery

Focus: Recent trends in nanoparticle-based drug delivery specifically for treating tuberculosis.

Size: Droplet sizes: 0.2-2 µm

17

17

Nanoemulsions for drug delivery

Key points: Nanoeulsions, surfactants, drug delivery, nanomedicine, peptide surfactant

Nanotech type: Novel drug-delivery

Focus: Nanoemulsions, nanomedicine.

19

18

Recent trends and advancements in nanoemulsions: production methods, functional properties, applications in food sector, safety and toxicological effects

Key points: Encapsulation,food industry, nanocoating, nutrient delivery, nanotechnology

Nanotech type: Nanoemulsions, nanoscale dispersions of immiscible liquids stabilized by surfactants.

Focus: Nanoemulsions for enhancing functional properties and applications in the food sector.

Size: 1-1 µm

20

19

Advancements in nanoemulsion-based drug delivery across different administration routes

Key points: Nanoemulsions; drug delivery; trans dermal; oral; ocular; nasal intra-articular

Nanotech type: Nanoemulsions-nanoscale colloidal dispersions of oil and water stabilized by surfactants, ranging from 50 to 500 nm in droplet size.

Focus: Advancements in nanoemulsion-based drug delivery across various administration routes, including (trans)dermal, oral, ocular, nasal, and intra-articular.

Size: droplet size: 0.5-5 µm

21

20

Nanogels: recent advances in synthesis and biomedical applications

Key points: Nanogels; nanoparticle synthesis; hydrogels and microgels; batch chemistry; flow chemistry; microfludics; nanimedicine; theranostics; crosslinking; drug delivery

Nanotech type: Nanogels nanoscale, cross-linked polymeric networks that can encapsulate drugs and respond to environmental stimuli

Focus: Recent advances in the synthesis and biomedical applications of nanogels, emphasizing their versatility and promising roles in drug delivery and imaging.

Size: 1-0.1 µm

23

21

A comprehensive review of nanogel-based drug delivery system

Key points: Swelling behavior, polymer, exceptional drug loading capability, drug delivery, nanogel

Nanotech type: Nanogels-crosslinked, nanoscale hydrogel particles that are stimuli-responsive and capable of encapsulating therapeutic agents for targeted delivery.

Focus: Comprehensive review of nanogel-based drug delivery systems, highlighting their advantages, synthesis, characterization, and therapeutic applications.

Size: Parenteral: 2 µm

Transdermal Delivery: below 0.5 µm

Ocular Delivery: below 2 µm

24

22

Biopolymer-based nanogel approach in drug delivery: basic concept and current developments

Key points: biopolymers; nanogels; drug delivery; polysaccharide-based nanogels; protein-based nanogels; nanotechnology

Nanotech type: Nanogels (polymeric hydrogel nanoparticles)

Focus: Biopolymer-based nanogels in drug delivery (concepts, design, applications).

25

23

Nanogels: A chemically versatile drug delivery platform

Key points: Nanogel, Hydrogel, Polymeric nanoparticle, Crosslinked polymer, Nanocarrier, Crosslinking copolymerization, Nanopolymerization encapsulation, stimulai-responsiveness, smart material, Targeted delivery, Drug delivery, Bottom-up synthesis

Nanotech type: Nanogels - crosslinked polymeric nanoparticles (nano-hydrogel networks) that can encapsulate varied payloads and respond to environmental triggers.

Focus: Nanogels as a chemically versatile platform for drug delivery, highlighting their tunability, stimuli responsiveness, and potential in precision therapeutics.

 

27

 

24

Advances in nanogels for topical drug delivery in ocular diseases

Key points: Nanogels, oscular diseases, drug delivery systems, natural polymers, contact lenses

Nanotech type: Nanogels - nanoscale, crosslinked polymeric hydrogel networks used as ocular drug carriers

Focus: Nanogels for topical drug delivery in ocular diseases (glaucoma, dry eye, keratitis, etc.).

28

25

Nanoparticles for drug delivery: insight into in vivo and in vitro drug release from nanomedicines

Key points: Nanoparticles, drug release, in vivo, in vitro, correlation, Nano-safety

Nanotech type: Nanoparticles (including organic, inorganic, and hybrid nanoparticles).

Focus: Nanoparticles for drug delivery, with special emphasis on In Vitro–In Vivo Drug Release Correlation (IVIVC)

Size: less than 2 µm and formulations being around 0.6-1.1 µm

29

26

Lipid-based nanoformulations for drug delivery: An ongoing

Key points: Liposomes, SLN, targeting, controlled release, solubility enhancement, vaccine, hydrophobic peptide, self-emulsifying

Nanotech type: Nanoparticles (especially surface-modified nanocarriers)

Focus: Modulation of nanoparticle behavior via surface engineering for improved drug delivery performance.

Size:0.2-2 µm

31

30

A recent update: solid lipid nanoparticles for effective drug delivery

Key points: solid lipid nanoparticles, (SLNs), method of preparation, route of administration, biological drugs, surface modified SLNs, patents

Nanotech type: Solid Lipid Nanoparticles (lipid-based nanocarriers)

Focus: Solid Lipid Nanoparticles (SLNs) for improved drug delivery (bioavailability, targeting, controlled release).

Size: Nanoscale officially end at 100 nm and drug delivery system up to 0.1 µm general goal of being smaller than 0.01µm for effective cell penetration.

32

31

Emulgel: An emerging novel drug delivery system

Key points: Cosmeceuticals, Gels, Emulgel, Emulsifying agents, Emulsions, Topical drug delivery

Nenotech type: Nanoemulsion-based emulgel - a nanotechnology type combining emulsions and gels for enhanced penetration and stability of herbal actives.

Focus: The study focuses on improving the topical delivery of hydrophobic herbal drugs using emulgel formulations that enhance skin absorption and therapeutic efficacy.

Size: 0.2-5 µm

33

32

A review on self-nanoemulsifying drug delivery system

Key points: Solubility, stability, bioavailability, hydrophobic drugs, triglycerides

Nenotech type: utilizes spontaneous formation of oil-in-water nanoemulsions upon contact with gastrointestinal fluids.

Focus: enhancing the solubility, stability, and bioavailability of poorly water-soluble drugs using self-nanoemulsifying drug delivery system (SNEDDS).

Size: 0.2 -2 µm

34

CONCLUSION

Nanotechnology represents a transformative frontier in pharmaceutical and biomedical research. Through the development of SLNs, nanogels, nano-emulsions, and various nanoparticle systems, it has become possible to design highly efficient, targeted, and controlled drug delivery platforms. These nanomaterials have demonstrated immense potential in improving therapeutic efficacy, reducing side effects, and overcoming biological barriers. Continuous advancements in formulation techniques and polymer science will further enhance the precision and safety of nanocarriers. However, addressing issues related to scalability, biocompatibility, and regulatory approval is essential for successful clinical translation. Overall, nanotechnology continues to pave the way for innovative solutions in medicine, diagnostics, and material science, promising a new era of advanced therapeutics.

REFERENCES

  1. Sastri, K. T., Radha, G.V., Pidikiti, S., and Vajjhala, P, “Solid lipid nanoparticles: Preparation techniques, their characterization, and an update on recent studies” Journal of Applied Pharmaceutical Science,2020,10, Page 126-141.
  2. Sebastian Scioli Montoto, Giuliana Muraca and Maria Esperanza Ruiz,“Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects” frontiers in Molecular Biosciences,2020, 7, Page 1-24.
  3. Yun Yan Shi, Xiao LI, Zhiyuan Li, Jialin Sun, Tong Gao, Gang Wei and Qie Guo, “Nano-formulations in disease therapy: designs, advances, challenges, and future directions” Journal of Nanobiotechnology,2025, 23,(396), Page 1-34.
  4. Meenu Mehta, Thuy Anh Bui, Xinpu Yang, Yagiz Aksoy, Ewa M. Goldys, and Wei Deng*, “Lipid-Based Nanoparticles for Drug/Gene Delivery: An Overview of the Production Techniques and Difficulties Encountered in Their Industrial Development” ACS MATERLALS AU,2023,3, Page 600-619.
  5. Sanja Petrovic, Bogdan Bita and Marcela-Elisabeta Barbinta-Patrascu, “Nanoformulations in Pharmaceutical and Biomedical Applications: Green Perspectives” International Journal of Molecular Sciences,2024,25, Page 1-67.
  6. Chandni Pachouri, Bharat Patel, Sandhya Shroti, Sandeep Shukla and Archna Pandey, “Recent Trends in Nanoparticles Based Drug Delivery for Tuberculosis Treatment” International Journal of Medical Nano Research,2021,8(1), Page1-11.
  7. Afzal, O.,Altamimi, A.S.A., Nadeem ,M.S., Alzarea ,S.I., Almalki, W.H., Tariq, A., Mubeen, B., “Nanoparticles in Drug Delivery: From History to Therapeutic Applications” Nanomaterials,2022,12 ,Page 1-27.
  8. Khiev, D., Mohamed, Z. A., Vichare, R., Paulson, R., Bhatia, S., Mohapatra, S., Lobo, G. P., C.L., Mohapatra, S. S., and Biswal, M. R, “Emerging Nano-Formulations and Nanomedicines Applications for Ocular Drug Delivery” Nanomaterials,2021,11, Page 1-18.
  9. Mohit Nagar, “Review on Nano-Emulsion Drug Delivery System and Formulation, Evaluation and Their Pharmaceutical Applications” International Journal of Health Care and Nursing (IJHCN), 2023, 2(1), Page 35-61.
  10. Preeti, Sambhakar, S., Malik, R., Bhatia, S., Al Harrasi, A., Rani, C., Saharan, R., Kumar, S., Geeta, and Sehrawat, R, “Nanoemulsion: An Emerging Novel Technology for Improving the Bioavailability of Drugs” Scientifica (Published by Hindawi), 2023
  11. Iordana Neamtu, Alina Gabriela Rusu, Alina Diaconu, Loredana Elena Nita, and Aurica P. Chiriac “Basic Concepts and recent advances in nanogels as carriers for medical applications” Drug Delivery, 2017,24(1), Page 539-55.
  12. Rakesh K. Sindhu, Rubal Gupta, Gaurish Wadhera and Pradeep Kumar, “Modern Herbal Nanogels: Formulation, Delivery Methods, and Applications” Gels, 2022,8(97), Page 1-23.
  13. Panoraia I. Siafaka, Ece Ozcan Bulbul, Mehmet Evren Okur, Ioannis D. Karantas and Neslihan Ustundag Okur “The Application of Nanogels as Efficient Drug Delivery Platforms for Dermal/Transdermal Delivery” Gels,2023, 9, Page 1-21.
  14. Nadeem A, Saqib Z, Arif A, Abid L, Shahzadi H, Saghir A, Khan E, Afzaal T, Saadat S, Rasheed N, Mustafa Ma, Iqbal Mz, “Hybrid Hydrogels Incorporating Nanoparticles, Their Types, Development, And Applications: A Comprehensive Review of Nanogels” Universal Journal of Pharmaceutical Research,2024,9(5), Page 142-149.
  15. Manimaran, V., Nivetha, R. P., Tamilanban, T., Narayanan, J., Vetriselvan, S., Fuloria, N. K., Chinni, S. V., Sekar, M., Fuloria, S., Wong, L. S., Biswas, A., Ramachawolran, G., and Selvaraj, S. “Nanogels as novel drug nanocarriers for CNS drug delivery” Fronties in Molecular Biosciences,2023,10, Page 1-18.
  16. Chavda, V.P., Balar, P. C., Bezbaruah, R., Vaghela, D. A., Rynjah, D., Bhattacharjee, B., Sugandhi, V. V., and Paiva-Santos, A. C, “Nanoemulsions: Summary of a decade of research and recent advances” Nanomedicine,2024,19(6), Page 519-536.
  17. Chandni Pachouri, Bharat Patel, Sandhya Shroti, Sandeep Shukla and Archna Pandey, “ Recent Trends in Nanoparticles Based Drug Delivery for Tuberculosis Treatment” International Journal of Medical Nano Research, 2021, Vol.8(1), Page 1-11. 
  18. Safiul Islam, Md Mir Shakib Ahmed, Mohammad Aminul Islam, Nayem Hossain, Mohammad Asaduzzaman Chowdhury, “Advances in nanoparticles in targeted drug delivery-A review” Results in Surfaces and Interfaces,2025,19, Page 1-19.
  19. Russell J. Wilson, Yang Li, Guangze Yang, Chun-Xia Zhao, “Nanoemulsions for drug delivery”, Particuology, 2022, 64, Page 85-97.
  20. Gurveer Kaur, Chirasmita Panigrahi, Swati Agarwal, Anjali Khuntia, Monalisa Sahoo, “Recent trends and advancements in nanoemulsions: Production methods, functional properties, applications in food sector, safety and toxicological effects” Food Physics,2024, Vol.1, Page 1-19.
  21. Maria D. Chatzidaki, and Evgenia Mitsou, “Advancements in Nanoemulsion-Based Drug Delivery Across Different Administration Routes” Pharmaceutics,2025, 17, Page 1-35.
  22. Muller, R.H.; Shegokar, R.; Keck, C.M. 20 years of lipid nanoparticles (SLN & NLC): Present state of development & industrial applications. Curr. Drug Discov. Technol. 2011, 8, 207–227.
  23. Pasquale Mastella, Biagio Todaro and Stefano Luin, “Nanogels: Recent Advances in Synthesis and Biomedical Applications” nanomaterials, 2024, 14, Page 1-28.
  24. Ferozekhan S,Marakanam S. Umashankar, Damodharan Narayanasamy, “A Comprehensive Review of Nanogel-Based Drug Delivery Systems” Cureus,2024,16(9), Page 1-12.
  25. Ebru Altuntas, Burcu Ozkan, Sevgi Gungor and Yildiz Ozsoy, “Biopolymer-Based Nanogel Approach in Drug Delivery: Basic Concept and Current Developments”, Pharmaceutics,2023,15(6), Page 1-33.
  26. Vashist, A., Alvarez, G. P., Camargo, V.A., Raymond, A. D., Arias, A. Y., Kolishetti, N., Vashist, D.A., Manickam, P., Aggarwal, S., and Nair, M., “Recent advances in nanogels for drug delivery and biomedical applications”, Biomaterials Science,2024,12, Page 6006-6018.
  27. Luka Blagojevic, Nazila Kamaly, “Nanogels: A Chemically Versatile Drug Delivery Platform”, Nano Today,2025,61, Page 1-33.
  28. Yongkang Wu, Qing Tao, Jing Xie, Lili Lu, Xiuli xie, Yang Zhang and Yong Jin, “Advances in Nanogels for Topical Drug Delivery in Ocular Diseases”, Gels,2023,9(4), Page 1-21.
  29. Ewii UE, Attama AA, Olorunsola EO, Onugwu AL, Nwakpa FU, Anyiam C, Chijioke C, Ogbulie T., “Nanoparticles for drug delivery: Insight into in vitro and in vivo drug release from nanomedicines”, Nano TransMed,2025,4, Page 1-30.
  30. Jayanta Kumar Patra, Gitishree Das,Leonardo Fernandes Fraceto,Estefania Vangelie Ramos Campos, Maria del Pilar Rodriguez-Torres, Laura Susana Acosta-Torres,Luis Armando Diaz-Torres, Renato Grillo, Mallappa Kumara Swamy, Shivesh sharma, Solomon Habtemariam and Han-Seung Shin, “Nano based drug delivery systems: recent developments and future prospects”, Journal of Nanobiotechnology,2018,16(71), Page 1-33.
  31. Rehman, M., Tahir, N., Sohail, M. F., Qadri, M. U., Duarte, S. O. D., Brandao, P., Esteves, T., Javed, I., and Fonte, P., “lipid-Based Nanoformulations for Drug Delivery: An Ongoing Perspective”, Pharmaceutics, 2024,16(11), Page 1-34.
  32. Sonia Pandey, Farhinbanu Shaikh, Arti Gupta, Purnima Tripathi, Jitendra Singh Yadav, “A Recent Update: Solid Lipid Nanoparticles for effective Drug Delivery”, Advanced Pharmaceutical Bulletin, 2022, 12(1), Page 17-33.
  33. Parth Jariwala, professor Kajal Vable, Dr Umesh Upadhyay, “Emulgel: An Emerging Novel Drug Delivery System”, Gradiva Review Journal, 2023,9(10), Page 476-495.
  34. Devesh Sharma, Kajal Vable, Dr Umesh upydhayay,“A Review On Self-Nanoemulsifying Drug Delivery System” , Gradiva Review Journal,2023, 9(11), Issue 11, Page 197-220.
  35. Sakshi Patel, Manisha Baria, Purvi Parmar, Nikita Patel, Neha Parmar, Kajal Vable*, Dr. Mitali Dalwadi, Dr. Priyanka Patil, Dr. Umesh Upadhyay, UV Spectroscopic Method Development and Validation for Simultaneous Estimation of Rebamipide and Omeprazole Magnesium in Synthetic Mixture, Int. J. of Pharm. Sci., 2025, 3(6), 669-679. https://doi.org/10.5281/zenodo.15594105
  36. Prajapati, H., Vable, K., Shah, C., Upadhyay, U., “A Review on HPLC analytical method and Validation for determination of sitagliptin phosphate in bulk and different dosage form”. International Journal of Pharmaceutical Science, 2024, 2(8): 3990-4007. 59.
  37. Vable, K., Upadhyay, U., “A Critical Analysis of Pharmaceutical Stability Testing. Bulletin for Technology and History”, 2024, 24(8): 233-243.
  38. Vable, K., Upadhyay, U., “A Comprehensive review of Analytical and Bio-analytical methods for Etoricoxib Determination. European journal of Biomedical and Pharmaceutical Sciences”, 2024, 11(11)5.
  39. P. Ekambaram, A. Abdul Hasan Sathali, K. Priyanka, “Solid Lipid Nanoparticles: A Review”, Sci. Revs. Chem. Commun, 2012, 2(1), 80-102.
  40. Urkunde A. Subodh, Atram C. Sandeep, Sable P. Rupali, Rajput J. Vrunda, Gawai G. Anuja, “A Comprehensive Review on Solid Lipid Nanoparticles”, Asian Journal of Pharmaceutical Research and Development, 2024; 12(1): 45-54
  41. Kartal-Yandim, M.; Adan-Gokbulut, A.; Baran, Y. Molecular mechanisms of drug resistance and its reversal in cancer. Crit. Rev. Biotechnol.,2016, 36, 716–726.
  42. Alakhova, D.Y.; Kabanov, A.V. Pluronics and MDR reversal: An update. Mol. Pharm., 2014, 11, 2566–2578.
  43. Bugde, P.; Biswas, R.; Merien, F.; Lu, J.; Liu, D.X.; Chen, M.; Zhou, S.; Li, Y. The therapeutic potential of targeting ABC transporters to combat multi-drug resistance. Expert Opin. Ther. Targets 2017, 21, 511–530.
  44. Cavaco, M.C.; Pereira, C.; Kreutzer, B.; Gouveia, L.F.; Silva-Lima, B.; Brito, A.M.; Videira, M. Evading P-glycoprotein mediated-efflux chemoresistance using solid lipid nanoparticles. Eur. J.  Pharm.Biopharm.2017, 110, 76–84.
  45. Bertrand, N.; Wu, J.; Xu, X.; Kamaly, N.; Farokhzad, O.C. Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology. Adv. Drug Deliv. Rev.,2014, 66, 2–25.
  46. Natfji, A.A.; Ravishankar, D.; Osborn, H.M.I.; Greco, F. Parameters affecting the enhanced permeability and retention effect: The need for patient selection. J. Pharm. Sci. 2017, 106, 3179–3187.
  47. Shah, R.; Eldridge, D.; Palombo, E.; Harding, I. Optimisation and stability assessment of solid lipid nanoparticles using particle size and zeta potential. J. Phys. Sci. 2014, 25, 59–75.
  48. Chen, Y.; Angelova, A.; Angelov, B.; Drechsler, M.; Garamus, V.M.;Willumeit-Römer, R.; Zou, A. Sterically stabilized spongosomes for multidrug delivery of anticancer nanomedicines. J. Mater. Chem. B, 2015, 3, 7734–7744.
  49. Nair, A.T.; Deshkar, S.S.; Boraste, S.S.; Sharma, R.M. Solid lipid nanoparticles a potential approach for delivery of lipophilic drugs: A review. J. Pharm. Pharm. Sci. 2016, 5, 2238–2253.
  50. Kajal Vable, Yaksh Gandhi, Khushi, Prajapati, Himani Vaghasiya, Dr. Mitali Dalwadi, Dr. Chainesh Shah, Dr. Priyanka Patil, Dr. Umesh Upadhyay, Khushbu Shah, A Comprehensive and Systemic Review on the. Development and Validation of Different Analytical Methods for the Estimation of Cyclobenzaprine, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 9, 1683-1689. https://doi.org/10.5281/zenodo.17122482.

Reference

  1. Sastri, K. T., Radha, G.V., Pidikiti, S., and Vajjhala, P, “Solid lipid nanoparticles: Preparation techniques, their characterization, and an update on recent studies” Journal of Applied Pharmaceutical Science,2020,10, Page 126-141.
  2. Sebastian Scioli Montoto, Giuliana Muraca and Maria Esperanza Ruiz,“Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects” frontiers in Molecular Biosciences,2020, 7, Page 1-24.
  3. Yun Yan Shi, Xiao LI, Zhiyuan Li, Jialin Sun, Tong Gao, Gang Wei and Qie Guo, “Nano-formulations in disease therapy: designs, advances, challenges, and future directions” Journal of Nanobiotechnology,2025, 23,(396), Page 1-34.
  4. Meenu Mehta, Thuy Anh Bui, Xinpu Yang, Yagiz Aksoy, Ewa M. Goldys, and Wei Deng*, “Lipid-Based Nanoparticles for Drug/Gene Delivery: An Overview of the Production Techniques and Difficulties Encountered in Their Industrial Development” ACS MATERLALS AU,2023,3, Page 600-619.
  5. Sanja Petrovic, Bogdan Bita and Marcela-Elisabeta Barbinta-Patrascu, “Nanoformulations in Pharmaceutical and Biomedical Applications: Green Perspectives” International Journal of Molecular Sciences,2024,25, Page 1-67.
  6. Chandni Pachouri, Bharat Patel, Sandhya Shroti, Sandeep Shukla and Archna Pandey, “Recent Trends in Nanoparticles Based Drug Delivery for Tuberculosis Treatment” International Journal of Medical Nano Research,2021,8(1), Page1-11.
  7. Afzal, O.,Altamimi, A.S.A., Nadeem ,M.S., Alzarea ,S.I., Almalki, W.H., Tariq, A., Mubeen, B., “Nanoparticles in Drug Delivery: From History to Therapeutic Applications” Nanomaterials,2022,12 ,Page 1-27.
  8. Khiev, D., Mohamed, Z. A., Vichare, R., Paulson, R., Bhatia, S., Mohapatra, S., Lobo, G. P., C.L., Mohapatra, S. S., and Biswal, M. R, “Emerging Nano-Formulations and Nanomedicines Applications for Ocular Drug Delivery” Nanomaterials,2021,11, Page 1-18.
  9. Mohit Nagar, “Review on Nano-Emulsion Drug Delivery System and Formulation, Evaluation and Their Pharmaceutical Applications” International Journal of Health Care and Nursing (IJHCN), 2023, 2(1), Page 35-61.
  10. Preeti, Sambhakar, S., Malik, R., Bhatia, S., Al Harrasi, A., Rani, C., Saharan, R., Kumar, S., Geeta, and Sehrawat, R, “Nanoemulsion: An Emerging Novel Technology for Improving the Bioavailability of Drugs” Scientifica (Published by Hindawi), 2023
  11. Iordana Neamtu, Alina Gabriela Rusu, Alina Diaconu, Loredana Elena Nita, and Aurica P. Chiriac “Basic Concepts and recent advances in nanogels as carriers for medical applications” Drug Delivery, 2017,24(1), Page 539-55.
  12. Rakesh K. Sindhu, Rubal Gupta, Gaurish Wadhera and Pradeep Kumar, “Modern Herbal Nanogels: Formulation, Delivery Methods, and Applications” Gels, 2022,8(97), Page 1-23.
  13. Panoraia I. Siafaka, Ece Ozcan Bulbul, Mehmet Evren Okur, Ioannis D. Karantas and Neslihan Ustundag Okur “The Application of Nanogels as Efficient Drug Delivery Platforms for Dermal/Transdermal Delivery” Gels,2023, 9, Page 1-21.
  14. Nadeem A, Saqib Z, Arif A, Abid L, Shahzadi H, Saghir A, Khan E, Afzaal T, Saadat S, Rasheed N, Mustafa Ma, Iqbal Mz, “Hybrid Hydrogels Incorporating Nanoparticles, Their Types, Development, And Applications: A Comprehensive Review of Nanogels” Universal Journal of Pharmaceutical Research,2024,9(5), Page 142-149.
  15. Manimaran, V., Nivetha, R. P., Tamilanban, T., Narayanan, J., Vetriselvan, S., Fuloria, N. K., Chinni, S. V., Sekar, M., Fuloria, S., Wong, L. S., Biswas, A., Ramachawolran, G., and Selvaraj, S. “Nanogels as novel drug nanocarriers for CNS drug delivery” Fronties in Molecular Biosciences,2023,10, Page 1-18.
  16. Chavda, V.P., Balar, P. C., Bezbaruah, R., Vaghela, D. A., Rynjah, D., Bhattacharjee, B., Sugandhi, V. V., and Paiva-Santos, A. C, “Nanoemulsions: Summary of a decade of research and recent advances” Nanomedicine,2024,19(6), Page 519-536.
  17. Chandni Pachouri, Bharat Patel, Sandhya Shroti, Sandeep Shukla and Archna Pandey, “ Recent Trends in Nanoparticles Based Drug Delivery for Tuberculosis Treatment” International Journal of Medical Nano Research, 2021, Vol.8(1), Page 1-11. 
  18. Safiul Islam, Md Mir Shakib Ahmed, Mohammad Aminul Islam, Nayem Hossain, Mohammad Asaduzzaman Chowdhury, “Advances in nanoparticles in targeted drug delivery-A review” Results in Surfaces and Interfaces,2025,19, Page 1-19.
  19. Russell J. Wilson, Yang Li, Guangze Yang, Chun-Xia Zhao, “Nanoemulsions for drug delivery”, Particuology, 2022, 64, Page 85-97.
  20. Gurveer Kaur, Chirasmita Panigrahi, Swati Agarwal, Anjali Khuntia, Monalisa Sahoo, “Recent trends and advancements in nanoemulsions: Production methods, functional properties, applications in food sector, safety and toxicological effects” Food Physics,2024, Vol.1, Page 1-19.
  21. Maria D. Chatzidaki, and Evgenia Mitsou, “Advancements in Nanoemulsion-Based Drug Delivery Across Different Administration Routes” Pharmaceutics,2025, 17, Page 1-35.
  22. Muller, R.H.; Shegokar, R.; Keck, C.M. 20 years of lipid nanoparticles (SLN & NLC): Present state of development & industrial applications. Curr. Drug Discov. Technol. 2011, 8, 207–227.
  23. Pasquale Mastella, Biagio Todaro and Stefano Luin, “Nanogels: Recent Advances in Synthesis and Biomedical Applications” nanomaterials, 2024, 14, Page 1-28.
  24. Ferozekhan S,Marakanam S. Umashankar, Damodharan Narayanasamy, “A Comprehensive Review of Nanogel-Based Drug Delivery Systems” Cureus,2024,16(9), Page 1-12.
  25. Ebru Altuntas, Burcu Ozkan, Sevgi Gungor and Yildiz Ozsoy, “Biopolymer-Based Nanogel Approach in Drug Delivery: Basic Concept and Current Developments”, Pharmaceutics,2023,15(6), Page 1-33.
  26. Vashist, A., Alvarez, G. P., Camargo, V.A., Raymond, A. D., Arias, A. Y., Kolishetti, N., Vashist, D.A., Manickam, P., Aggarwal, S., and Nair, M., “Recent advances in nanogels for drug delivery and biomedical applications”, Biomaterials Science,2024,12, Page 6006-6018.
  27. Luka Blagojevic, Nazila Kamaly, “Nanogels: A Chemically Versatile Drug Delivery Platform”, Nano Today,2025,61, Page 1-33.
  28. Yongkang Wu, Qing Tao, Jing Xie, Lili Lu, Xiuli xie, Yang Zhang and Yong Jin, “Advances in Nanogels for Topical Drug Delivery in Ocular Diseases”, Gels,2023,9(4), Page 1-21.
  29. Ewii UE, Attama AA, Olorunsola EO, Onugwu AL, Nwakpa FU, Anyiam C, Chijioke C, Ogbulie T., “Nanoparticles for drug delivery: Insight into in vitro and in vivo drug release from nanomedicines”, Nano TransMed,2025,4, Page 1-30.
  30. Jayanta Kumar Patra, Gitishree Das,Leonardo Fernandes Fraceto,Estefania Vangelie Ramos Campos, Maria del Pilar Rodriguez-Torres, Laura Susana Acosta-Torres,Luis Armando Diaz-Torres, Renato Grillo, Mallappa Kumara Swamy, Shivesh sharma, Solomon Habtemariam and Han-Seung Shin, “Nano based drug delivery systems: recent developments and future prospects”, Journal of Nanobiotechnology,2018,16(71), Page 1-33.
  31. Rehman, M., Tahir, N., Sohail, M. F., Qadri, M. U., Duarte, S. O. D., Brandao, P., Esteves, T., Javed, I., and Fonte, P., “lipid-Based Nanoformulations for Drug Delivery: An Ongoing Perspective”, Pharmaceutics, 2024,16(11), Page 1-34.
  32. Sonia Pandey, Farhinbanu Shaikh, Arti Gupta, Purnima Tripathi, Jitendra Singh Yadav, “A Recent Update: Solid Lipid Nanoparticles for effective Drug Delivery”, Advanced Pharmaceutical Bulletin, 2022, 12(1), Page 17-33.
  33. Parth Jariwala, professor Kajal Vable, Dr Umesh Upadhyay, “Emulgel: An Emerging Novel Drug Delivery System”, Gradiva Review Journal, 2023,9(10), Page 476-495.
  34. Devesh Sharma, Kajal Vable, Dr Umesh upydhayay,“A Review On Self-Nanoemulsifying Drug Delivery System” , Gradiva Review Journal,2023, 9(11), Issue 11, Page 197-220.
  35. Sakshi Patel, Manisha Baria, Purvi Parmar, Nikita Patel, Neha Parmar, Kajal Vable*, Dr. Mitali Dalwadi, Dr. Priyanka Patil, Dr. Umesh Upadhyay, UV Spectroscopic Method Development and Validation for Simultaneous Estimation of Rebamipide and Omeprazole Magnesium in Synthetic Mixture, Int. J. of Pharm. Sci., 2025, 3(6), 669-679. https://doi.org/10.5281/zenodo.15594105
  36. Prajapati, H., Vable, K., Shah, C., Upadhyay, U., “A Review on HPLC analytical method and Validation for determination of sitagliptin phosphate in bulk and different dosage form”. International Journal of Pharmaceutical Science, 2024, 2(8): 3990-4007. 59.
  37. Vable, K., Upadhyay, U., “A Critical Analysis of Pharmaceutical Stability Testing. Bulletin for Technology and History”, 2024, 24(8): 233-243.
  38. Vable, K., Upadhyay, U., “A Comprehensive review of Analytical and Bio-analytical methods for Etoricoxib Determination. European journal of Biomedical and Pharmaceutical Sciences”, 2024, 11(11)5.
  39. P. Ekambaram, A. Abdul Hasan Sathali, K. Priyanka, “Solid Lipid Nanoparticles: A Review”, Sci. Revs. Chem. Commun, 2012, 2(1), 80-102.
  40. Urkunde A. Subodh, Atram C. Sandeep, Sable P. Rupali, Rajput J. Vrunda, Gawai G. Anuja, “A Comprehensive Review on Solid Lipid Nanoparticles”, Asian Journal of Pharmaceutical Research and Development, 2024; 12(1): 45-54
  41. Kartal-Yandim, M.; Adan-Gokbulut, A.; Baran, Y. Molecular mechanisms of drug resistance and its reversal in cancer. Crit. Rev. Biotechnol.,2016, 36, 716–726.
  42. Alakhova, D.Y.; Kabanov, A.V. Pluronics and MDR reversal: An update. Mol. Pharm., 2014, 11, 2566–2578.
  43. Bugde, P.; Biswas, R.; Merien, F.; Lu, J.; Liu, D.X.; Chen, M.; Zhou, S.; Li, Y. The therapeutic potential of targeting ABC transporters to combat multi-drug resistance. Expert Opin. Ther. Targets 2017, 21, 511–530.
  44. Cavaco, M.C.; Pereira, C.; Kreutzer, B.; Gouveia, L.F.; Silva-Lima, B.; Brito, A.M.; Videira, M. Evading P-glycoprotein mediated-efflux chemoresistance using solid lipid nanoparticles. Eur. J.  Pharm.Biopharm.2017, 110, 76–84.
  45. Bertrand, N.; Wu, J.; Xu, X.; Kamaly, N.; Farokhzad, O.C. Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology. Adv. Drug Deliv. Rev.,2014, 66, 2–25.
  46. Natfji, A.A.; Ravishankar, D.; Osborn, H.M.I.; Greco, F. Parameters affecting the enhanced permeability and retention effect: The need for patient selection. J. Pharm. Sci. 2017, 106, 3179–3187.
  47. Shah, R.; Eldridge, D.; Palombo, E.; Harding, I. Optimisation and stability assessment of solid lipid nanoparticles using particle size and zeta potential. J. Phys. Sci. 2014, 25, 59–75.
  48. Chen, Y.; Angelova, A.; Angelov, B.; Drechsler, M.; Garamus, V.M.;Willumeit-Römer, R.; Zou, A. Sterically stabilized spongosomes for multidrug delivery of anticancer nanomedicines. J. Mater. Chem. B, 2015, 3, 7734–7744.
  49. Nair, A.T.; Deshkar, S.S.; Boraste, S.S.; Sharma, R.M. Solid lipid nanoparticles a potential approach for delivery of lipophilic drugs: A review. J. Pharm. Pharm. Sci. 2016, 5, 2238–2253.
  50. Kajal Vable, Yaksh Gandhi, Khushi, Prajapati, Himani Vaghasiya, Dr. Mitali Dalwadi, Dr. Chainesh Shah, Dr. Priyanka Patil, Dr. Umesh Upadhyay, Khushbu Shah, A Comprehensive and Systemic Review on the. Development and Validation of Different Analytical Methods for the Estimation of Cyclobenzaprine, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 9, 1683-1689. https://doi.org/10.5281/zenodo.17122482.

Photo
Kajal Vable
Corresponding author

Sigma Institute of Pharmacy, Sigma University, Bakrol, Vadodara-390019, Gujarat.

Photo
Khushi Prajapati
Co-author

Sigma Institute of Pharmacy, Sigma University, Bakrol, Vadodara-390019, Gujarat.

Photo
Himani Vaghasiya
Co-author

Sigma Institute of Pharmacy, Sigma University, Bakrol, Vadodara-390019, Gujarat.

Photo
Dr. Mitali Dalwadi
Co-author

Sigma Institute of Pharmacy, Sigma University, Bakrol, Vadodara-390019, Gujarat.

Photo
Dr. Priyanka Patil
Co-author

Sigma Institute of Pharmacy, Sigma University, Bakrol, Vadodara-390019, Gujarat.

Khushi Prajapati, Himani Vaghasiya, Kajal Vable*, Dr. Mitali Dalwadi, Dr. Priyanka Patil, Focus on Nanotechnology: A Brief Overview of Important Nanomaterials and Their Diverse Uses, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 10, 1933-1951 https://doi.org/10.5281/zenodo.17383394

More related articles
A Brief Review on Phyllanthus emblica Linn Seeds...
N. Sangeetha, P. Muthusamy, R. Vijaya Bharathi, G. Kaviya, R. Rad...
Zosurabalpin as The Primary Focus in Pneumonia Pha...
Dr. Garlapati Usha Kiran, Prasanna Thumpati, Siva Gowri Tanuja Ra...
A Brief Review on Preparation and Evaluation Herbal Shampoo...
Ramesh M., Sachin D., Rekha K., Mullaikodi O., ...
A Brief Review on Polyherbal Extract Having Anti-Inflammatory Activity...
Rahmabi Kuttipuravan , Ansila K. V, Gayathri A, Muhammad Yaseen , Rasha Sherin K V, Shifna Nishin P,...
Related Articles
Amoebic Meningitis: Current Challenges and Emerging Threats with Special Focus o...
Divya Raj, Remya Gayathri S, Adithya Ratheesh, Ashly Raju, Avani Kannan, Nandana Murali, Raniya Shem...
Thiocolchicoside: A Brief Review...
K. S. S. Chakravarthi, K. B. Ilango, E. D. Ananya, D. Dinesh, A. Karthikeyan, P. Suwathi, R. Rathi, ...
Recent Advances in HIV Diagnosis and Treatment: A Focus on Novel Antiretroviral ...
T. V. Sowjanya, Anne Sai Anusha, Shaik Vahin, Bezawada Sujitha, Puli Lahari, Vemuluru Kavya Sri, ...
Dapagliflozin and Bisoprolol: A Brief Review...
K. S. S. Chakravarthi, K. B Ilango, S. Jeevitha, S. Kamalakannan, S. Kesavan, S. Sanjaya krishnan, M...
A Brief Review on Phyllanthus emblica Linn Seeds...
N. Sangeetha, P. Muthusamy, R. Vijaya Bharathi, G. Kaviya, R. Radha, ...
More related articles
A Brief Review on Phyllanthus emblica Linn Seeds...
N. Sangeetha, P. Muthusamy, R. Vijaya Bharathi, G. Kaviya, R. Radha, ...
Zosurabalpin as The Primary Focus in Pneumonia Pharmacological Actions...
Dr. Garlapati Usha Kiran, Prasanna Thumpati, Siva Gowri Tanuja Ramanadham, Pavithra Gadde, Nandini R...
A Brief Review on Phyllanthus emblica Linn Seeds...
N. Sangeetha, P. Muthusamy, R. Vijaya Bharathi, G. Kaviya, R. Radha, ...
Zosurabalpin as The Primary Focus in Pneumonia Pharmacological Actions...
Dr. Garlapati Usha Kiran, Prasanna Thumpati, Siva Gowri Tanuja Ramanadham, Pavithra Gadde, Nandini R...